Experience
GlaxoSmithKline
Alphapharm
Represented GlaxoSmithKline in multiple ANDA challenges to Orange Book listed patents covering its Paxil® pharmaceutical product.
GlaxoSmithKline v. Alphapharm, 2:01-cv-01027; 2:01-cv-03364; 2:02-cv-08493, E.D. Pa., Judges Baylson, Surrick
Urologix Inc. v. Prostalund AB
ACMI Circon Corp.
Aventis Behring LLC v. Bayer Corp.
Aventis Behring LLC
Nova Design Technologies Ltd. v. Children's Medical Ventures
Children's Medical Ventures; Philips
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
Avid Radiopharmaceuticals
Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
AstraZeneca Pharmaceuticals LP
USPTO cancels all claims for Finnegan client CRS in second CBM proceeding (in favor of)
CRS Advanced Technologies
Monta Vista
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.